Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights

Triple negative breast cancer (TNBC) heterogeneity and limited therapeutic options confer its phenotypic aggressiveness. The discovery of anti-TNBC natural products with valid molecular target(s) and defined pharmacodynamic profile would facilitate their therapeutic nutraceutical use by TNBC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Qusa, Mohammed H., Abdelwahed, Khaldoun S., Siddique, Abu Bakar, El Sayed, Khalid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157589/
https://www.ncbi.nlm.nih.gov/pubmed/34069906
http://dx.doi.org/10.3390/nu13051706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157589/
https://www.ncbi.nlm.nih.gov/pubmed/34069906
http://dx.doi.org/10.3390/nu13051706

Ejemplares similares